CoLucid

Eli Lilly Acquires CoLucid Pharma, Adds Migraine Drug to Pipeline
TheStreet.com
Wed, 01/18/17 - 10:09 am
Eli Lilly
CoLucid
M&A
migraines
Lasmiditan
Biotech's Top 3 Stock Losers, and Winners, in 2016
Forbes
Mon, 01/2/17 - 12:03 pm
biotech
Concordia
Ophthotech
Cempra
Corbus Pharmaceuticals
CoLucid
AveXis
On the road to Cambridge, migraine drug biotech CoLucid files for an $86M IPO
Fierce Biotech
Tue, 03/31/15 - 03:57 pm
CoLucid
IPOs
migraines